Skip to main content
. 2022 Nov 11;101(45):e31522. doi: 10.1097/MD.0000000000031522

Figure 4.

Figure 4.

The gene expression of interferon-inducible genes in the peripheral blood mononuclear cells (PBMCs) of patients with systemic lupus erythematosus (SLE), patients with rheumatoid arthritis (RA), and healthy donors (HDs). Each symbol represents an individual sample; horizontal lines show median values. (A) In the patients with SLE, the gene expression of interferon-inducible protein with tetratricopeptide 1 (IFIT1) was significantly higher than that in the HDs and patients with RA. (B) In the patients with SLE, the gene expression of interferon-inducible protein 44 (IFI44) was significantly higher than in the HDs and patients with RA. (C) In the patients with SLE, the gene expression of eukaryotic translation initiation factor 2 alpha kinase 2 (EIF2AK2) was significantly higher than in the HDs and patients with RA.